Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CoQ10 (Q-Absorb) - Nutraceuticals World

What are you searching for?

Sign in
Research

CoQ10 (Q-Absorb)

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Indication: Heart disease

Source: 3rd Annual International CoQ10 Conference, London, U.K.

Research: Italian scientists at the University of Ancona Hospital conducted a study that investigated biological endpoints such as functional capacity and ischemic threshold, in a randomized, placebo-controlled, crossover clinical trial. Twenty-one subjects with ischemic heart disease and heart failure were monitored for the effects of Q-Absorb 300 mg daily 100 mg t.i.d., exercise therapy and Q-Absorb plus exercise therapy versus placebo.
 
Results: Q-Absorb administration re­sulted in significant elevations in plasma CoQ10 averaging 3.7 mcg/mL plasma, peripheral arterial dilation and in­crease in peak VO2 (volume of oxygen consumed). The co-administration of Q-Absorb and exercise therapy resulted in the greatest gains, with endothelial dysfunction being almost normalized.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters